Several studies have shown that GPS has higher prognostic power than PNI in patients undergoing dialysis; however, its application in current routine clinical practice is limited due to cost and specific clinical situations for measuring CRP (e.g., active infection status) [17,20]. This evidence concerns the gene CRP and infection.